Annual EBIT
-$248.73 M
-$87.23 M-54.02%
31 December 2023
Summary:
10x Genomics annual earnings before interest & taxes is currently -$248.73 million, with the most recent change of -$87.23 million (-54.02%) on 31 December 2023. During the last 3 years, it has risen by +$284.06 million (+53.32%). TXG annual EBIT is now -1287.23% below its all-time high of -$13.63 million.TXG EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$34.44 M
+$2.64 M+7.13%
30 September 2024
Summary:
10x Genomics quarterly earnings before interest & taxes is currently -$34.44 million, with the most recent change of +$2.64 million (+7.13%) on 30 September 2024. Over the past year, it has increased by +$57.31 million (+62.46%). TXG quarterly EBIT is now -1080.12% below its all-time high of -$2.92 million, reached on 31 March 2019.TXG Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$175.91 M
+$57.31 M+24.57%
30 September 2024
Summary:
10x Genomics TTM earnings before interest & taxes is currently -$175.91 million, with the most recent change of +$57.31 million (+24.57%) on 30 September 2024. Over the past year, it has increased by +$42.52 million (+19.47%). TXG TTM EBIT is now -1099.09% below its all-time high of -$14.67 million, reached on 30 September 2018.TXG TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TXG EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -54.0% | +62.5% | +19.5% |
| 3 y3 years | +53.3% | -109.6% | +60.5% |
| 5 y5 years | -126.1% | -287.5% | -81.9% |
TXG EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -370.6% | +53.3% | -118.3% | +62.5% | -232.8% | +60.5% |
| 5 y | 5 years | -789.8% | +53.3% | -470.7% | +91.6% | -529.3% | +67.0% |
| alltime | all time | -1287.2% | +53.3% | -1080.1% | +91.6% | -1099.1% | +67.0% |
10x Genomics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$34.44 M(-7.1%) | -$175.91 M(-24.6%) |
| June 2024 | - | -$37.08 M(-35.9%) | -$233.21 M(-9.2%) |
| Mar 2024 | - | -$57.80 M(+24.1%) | -$256.90 M(+3.3%) |
| Dec 2023 | -$248.73 M(+54.0%) | -$46.59 M(-49.2%) | -$248.73 M(+13.9%) |
| Sept 2023 | - | -$91.74 M(+51.0%) | -$218.43 M(+31.1%) |
| June 2023 | - | -$60.76 M(+22.4%) | -$166.60 M(-1.7%) |
| Mar 2023 | - | -$49.63 M(+204.8%) | -$169.56 M(+5.0%) |
| Dec 2022 | -$161.50 M(+205.6%) | -$16.29 M(-59.2%) | -$161.50 M(+0.3%) |
| Sept 2022 | - | -$39.92 M(-37.4%) | -$160.99 M(+17.1%) |
| June 2022 | - | -$63.72 M(+53.3%) | -$137.49 M(+64.6%) |
| Mar 2022 | - | -$41.57 M(+163.5%) | -$83.52 M(+58.0%) |
| Dec 2021 | -$52.85 M | -$15.78 M(-4.0%) | -$52.85 M(-88.1%) |
| Sept 2021 | - | -$16.43 M(+68.5%) | -$445.38 M(-9.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | -$9.75 M(-10.5%) | -$493.82 M(-5.7%) |
| Mar 2021 | - | -$10.89 M(-97.3%) | -$523.51 M(-1.7%) |
| Dec 2020 | -$532.79 M(+1806.0%) | -$408.31 M(+529.5%) | -$532.79 M(+308.2%) |
| Sept 2020 | - | -$64.87 M(+64.5%) | -$130.52 M(+75.1%) |
| June 2020 | - | -$39.44 M(+95.4%) | -$74.54 M(+64.8%) |
| Mar 2020 | - | -$20.18 M(+234.5%) | -$45.22 M(+61.8%) |
| Dec 2019 | -$27.95 M(-74.6%) | -$6.03 M(-32.1%) | -$27.95 M(-71.1%) |
| Sept 2019 | - | -$8.89 M(-12.1%) | -$96.71 M(-5.6%) |
| June 2019 | - | -$10.12 M(+246.6%) | -$102.50 M(+10.9%) |
| Mar 2019 | - | -$2.92 M(-96.1%) | -$92.38 M(+3.3%) |
| Dec 2018 | -$109.99 M(+513.4%) | -$74.79 M(+409.8%) | -$89.46 M(+509.8%) |
| Sept 2018 | - | -$14.67 M | -$14.67 M |
| Dec 2017 | -$17.93 M | - | - |
FAQ
- What is 10x Genomics annual earnings before interest & taxes?
- What is the all time high annual EBIT for 10x Genomics?
- What is 10x Genomics annual EBIT year-on-year change?
- What is 10x Genomics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for 10x Genomics?
- What is 10x Genomics quarterly EBIT year-on-year change?
- What is 10x Genomics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for 10x Genomics?
- What is 10x Genomics TTM EBIT year-on-year change?
What is 10x Genomics annual earnings before interest & taxes?
The current annual EBIT of TXG is -$248.73 M
What is the all time high annual EBIT for 10x Genomics?
10x Genomics all-time high annual earnings before interest & taxes is -$13.63 M
What is 10x Genomics annual EBIT year-on-year change?
Over the past year, TXG annual earnings before interest & taxes has changed by -$87.23 M (-54.02%)
What is 10x Genomics quarterly earnings before interest & taxes?
The current quarterly EBIT of TXG is -$34.44 M
What is the all time high quarterly EBIT for 10x Genomics?
10x Genomics all-time high quarterly earnings before interest & taxes is -$2.92 M
What is 10x Genomics quarterly EBIT year-on-year change?
Over the past year, TXG quarterly earnings before interest & taxes has changed by +$57.31 M (+62.46%)
What is 10x Genomics TTM earnings before interest & taxes?
The current TTM EBIT of TXG is -$175.91 M
What is the all time high TTM EBIT for 10x Genomics?
10x Genomics all-time high TTM earnings before interest & taxes is -$14.67 M
What is 10x Genomics TTM EBIT year-on-year change?
Over the past year, TXG TTM earnings before interest & taxes has changed by +$42.52 M (+19.47%)